San Francisco, CA · Founded 2014 · Privately Held (backing)
Developer of novel B-cell therapies and drugs designed to address significant unmet clinical needs of autoimmunity. BioGraph 55 is based in San Francisco, CA and was founded in 2014. Its last known valuation is $25 million. It has raised $20.1 million.
Last price · $/share
—
Implied valuation
$25.0M
Total raised
$20.1M
Last round
—
Team — not yet on record
No current team members for BioGraph 55 are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioGraph 55 with a free account
·Watch BioGraph 55: the Monday email on marks, rounds and moves
